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The preponderance of experimental and
human data indicates that there are persistent
and deleterious effects of blood lead levels
> 10 µg/dL on brain function, including low-
ered intelligence, behavioral problems, and
diminished school performance (Baghurst
et al. 1992; Bellinger et al. 1992; Cory-Slechta
1997; Dietrich et al. 1993; Ernhart et al. 1989;
National Research Council 1993; Needleman
and Gatsonis 1990; Pocock et al. 1994; Rice
1993; Wasserman et al. 1997; Yule et al.
1981). Lead toxicity, deﬁned as whole blood
lead ≥ 10 µg/dL, was based on numerous
cross-sectional and prospective studies
[Bellinger et al. 1987; Centers for Disease
Control and Prevention (CDC) 1991; World
Health Organization (WHO) 1995]. These
studies generally, but not always, found
adverse consequences of childhood lead expo-
sure (CDC 1991; WHO 1995). Still, most of
the children in those studies had blood lead
levels > 10 µg/dL. The WHO and the CDC
recognized that there was no discernable
threshold for the adverse effects of lead expo-
sure, but too few studies had examined chil-
dren with blood lead levels < 10 µg/dL to
support any firm conclusions (CDC 1991;
WHO 1995).
There is emerging evidence that lead-
associated intellectual deﬁcits occur at blood
lead levels < 10 µg/dL. In the Rochester
Longitudinal Study, there was an estimated
reduction of 7.4 IQ points associated with an
increase in lifetime mean blood lead from
1 to 10 µg/dL (Canfield et al. 2003). In a
reanalysis of a Boston, Massachusetts, cohort,
a similar finding was observed among chil-
dren whose maximal blood lead level was
< 10 µg/dL (Bellinger and Needleman 2003).
Questions about an effect of lead at blood
lead levels < 10 µg/dL persist, however,
because of the relatively small numbers of
children with maximal blood lead levels
< 10 µg/dL in the Rochester Longitudinal
Study (Rogan and Ware 2003). Other studies
were limited because they involved children
whose blood lead levels may have exceeded
10 µg/dL at some point in their lifetime or
because important covariates, such as maternal
IQ scores, were not always available (Fulton
et al. 1987; Lanphear et al. 2000; Schwartz
1994; Schwartz and Otto 1991; Walkowiak
et al. 1998). Because of the policy implica-
tions of this research, it is critical to estimate
with greater precision the exposure–response
relationship at blood lead levels < 10 µg/dL.
The primary objective of this pooled analy-
sis was to estimate the quantitative relationship
between children’s performance on IQ tests
and selected measures of blood lead concentra-
tion among children followed prospectively,
from infancy through 5–10 years of age in
seven prospective cohort studies. We also
sought to test whether the lead-associated IQ
deﬁcit was greater for a given change in expo-
sure among children who had maximal blood
lead levels < 10 µg/dL compared with children
who had higher blood lead concentrations.
Materials and Methods
We contacted investigators for all eight
prospective lead cohorts that were initiated
before 1995, and we were able to retrieve data
sets and collaboration from seven. The par-
ticipating sites were Boston (Bellinger et al.
1992); Cincinnati (Dietrich et al. 1993) and
Cleveland, Ohio (Ernhart et al. 1989);
Mexico City, Mexico (Schnaas et al. 2000);
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Lead is a conﬁrmed neurotoxin, but questions remain about lead-associated intellectual deﬁcits at
blood lead levels < 10 µg/dL and whether lower exposures are, for a given change in exposure, asso-
ciated with greater deﬁcits. The objective of this study was to examine the association of intelli-
gence test scores and blood lead concentration, especially for children who had maximal measured
blood lead levels < 10 µg/dL. We examined data collected from 1,333 children who participated in
seven international population-based longitudinal cohort studies, followed from birth or infancy
until 5–10 years of age. The full-scale IQ score was the primary outcome measure. The geometric
mean blood lead concentration of the children peaked at 17.8 µg/dL and declined to 9.4 µg/dL by
5–7 years of age; 244 (18%) children had a maximal blood lead concentration < 10 µg/dL, and
103 (8%) had a maximal blood lead concentration < 7.5 µg/dL. After adjustment for covariates,
we found an inverse relationship between blood lead concentration and IQ score. Using a log-
linear model, we found a 6.9 IQ point decrement [95% conﬁdence interval (CI), 4.2–9.4] associ-
ated with an increase in concurrent blood lead levels from 2.4 to 30 µg/dL. The estimated IQ
point decrements associated with an increase in blood lead from 2.4 to 10 µg/dL, 10 to 20 µg/dL,
and 20 to 30 µg/dL were 3.9 (95% CI, 2.4–5.3), 1.9 (95% CI, 1.2–2.6), and 1.1 (95% CI,
0.7–1.5), respectively. For a given increase in blood lead, the lead-associated intellectual decre-
ment for children with a maximal blood lead level < 7.5 µg/dL was signiﬁcantly greater than that
observed for those with a maximal blood lead level ≥ 7.5 µg/dL (p = 0.015). We conclude that
environmental lead exposure in children who have maximal blood lead levels < 7.5 µg/dL is asso-
ciated with intellectual deficits. Key words: blood lead concentration, children, environment,
epidemiology, intelligence, lead, lead toxicity. Environ Health Perspect 113:894–899 (2005).
doi:10.1289/ehp.7688 available via http://dx.doi.org/ [Online 18 March 2005]Port Pirie, Australia (Baghurst et al. 1992);
Rochester, New York (Canﬁeld et al. 2003);
and Yugoslavia (Wasserman et al. 1997). The
Sydney, Australia, study was not included
because we were unable to contact the investi-
gators (Cooney et al. 1989). The data for the
Rochester Longitudinal Study and for Mexico
City, collected when the children were about
6 years of age, have not been published else-
where. The eligibility criteria and methods for
each of the cohorts are described elsewhere
(Baghurst et al. 1992; Bellinger et al. 1992;
Canfield et al. 2003; Dietrich et al. 1993;
Ernhart et al. 1989; Schnaas et al. 2000;
Wasserman et al. 1997). All studies were
approved by their respective institutional
review boards.
Outcome measures. The primary outcome
measure was the full-scale IQ, which is a com-
posite score of verbal and performance tests.
The children were administered a version of the
Wechsler Intelligence Scales for Children
[Wechsler Intelligence Scale for Children–
Revised (WISC-R; Wechsler 1974), Wechsler
Intelligence Scale for Children–III (WISC-III;
Wechsler 1991), Wechsler Preschool and
Primary Scales of Intelligence (WPPSI; 1967),
and Wechsler Intelligence Scale for Children–
Spanish Version (WISC-S; Wechsler 1981)]
under uniform conditions within each study.
The IQ test was administered when the children
were between 4 years 10 months and 7 years of
age for all but one cohort. In the Boston cohort,
we used blood lead tests taken at 5 years of age
and the nearest available full-scale IQ score,
which was done at 10 years of age.
Venous or ﬁngerstick capillary blood sam-
ples were obtained using standard protocols.
Cord blood lead was collected in a subsample
of the subjects. During each child’s examina-
tion, demographic and health information
were obtained from the parent (usually the
biologic mother). IQ tests were administered
to the mother. We also obtained data on other
factors that might confound the relation of
lead exposure and IQ, including child’s sex,
birth order, birth weight, maternal education,
maternal age, marital status, prenatal alcohol
exposure, prenatal tobacco exposure, and the
Home Observation for Measurement of the
Environment (HOME) Inventory score. The
HOME Inventory is an index that reﬂects the
quality and quantity of emotional and cogni-
tive stimulation in the home environment
(Caldwell and Bradley 1984).
Measures of exposure. We examined four
measures of blood lead: concurrent blood lead
(defined as the blood lead measured closest
to the IQ test), maximum blood lead level
(defined as the peak blood lead measured at
any time before IQ test), average lifetime blood
lead (defined as the mean blood lead from
6 months to concurrent blood lead tests), and
early childhood blood lead (defined as the
mean blood lead from 6 to 24 months). The
blood sampling intervals varied across studies.
To enhance comparability across studies, we
used the following blood sampling intervals
(based on children’s age): 6, 12 (or 15), 36, 48,
and 60 months. We used mean blood lead
rather than area under the curve (AUC) to
maintain the same units of analysis for all four
lead indices. The AUC and mean provided
essentially the same information about chil-
dren’s lead exposure (r = 0.97).
Statistical methods. To estimate the quan-
titative relationship between children’s perfor-
mance on IQ tests and selected measures of
blood lead concentration, we examined the
potential confounding effects of other factors
associated with IQ scores using multiple
regression analysis. Ten factors were available
from individual sites: HOME Inventory,
child’s sex, birth weight, birth order, maternal
education, maternal IQ, maternal age, marital
status, prenatal smoking status, and prenatal
alcohol use.
The development of the regression model
involved a multistep process beginning with a
simple unadjusted model relating each blood
lead measure to IQ while controlling for site.
The first step was to test whether the linear
model of the relationship between blood lead
and IQ, applied in most of the individual
cohort analyses, provided a good ﬁt over the
wider range of blood lead levels represented in
the pooled data. First, a linear model adjusted
for the seven sites was estimated, and then
quadratic and cubic terms for blood lead were
added to test for linearity. A restricted cubic
spline function was ﬁt to the data to produce
a curve that followed the data in the absence
of any assumptions about the functional form
of the relationship.
After an initial model was chosen, we
examined each of the 10 available confounders
individually and in combination with the
other covariates to assess potential confound-
ing of the IQ–blood lead relationship. Careful
attention was paid to the stability of the para-
meter estimates as each additional term was
added. This process was halted when either no
more signiﬁcant terms (p < 0.10) entered the
model or the inclusion of additional terms
caused no substantial change (i.e., > 10%) in
the blood lead coefﬁcient.
In all models, we tested the interaction
of blood lead and site to determine whether
a summary measure of the IQ–blood lead
relationship could be used for all cohorts.
After an initial model was selected, the tests
of linearity and the restricted cubic spline
models were recomputed to ensure that our
initial model was still appropriate after adjust-
ment for covariates (Harrell 2001). We also
produced separate linear models for each of
the seven cohorts adjusted for the covariates
selected in the combined model.
After the multiple regression models
were developed, regression diagnostics were
employed to ascertain whether the lead coefﬁ-
cient was affected by collinearity or inﬂuential
observations (Belsley et al. 1980). After regres-
sion diagnostics were examined and homo-
geneity of the blood lead coefficients across
sites was evaluated, the ﬁt of all four measures
of blood lead was compared using the magni-
tude of the model R2. The blood lead measure
with the largest R2 (adjusted for the same
covariates) was selected a priori as the preferred
blood lead index relating blood lead to IQ.
Several approaches were investigated to
evaluate the stability of the final model.
Although the seven cohorts were not randomly
sampled from a larger population of studies, an
assumption could be made that they were rep-
resentative of a larger population of children.
Accordingly, we evaluated the results of apply-
ing a random-effects model (with sites ran-
dom) rather than a ﬁxed-effects model (Littell
et al. 1996). We also examined the effect of
any one site on the overall model by calculat-
ing the blood lead coefﬁcient in seven identical
models, each omitting one of the seven cohorts
(Efron and Tibshirani 1993).
After the ﬁnal model was selected using the
full-scale IQ as the outcome variable, we fit
similar models for verbal and performance
IQ scores. We also examined interactions of
covariates with blood lead concentration (effect
modiﬁcation) and tested the effect of including
race as a confounder in the U.S. cohort studies.
Finally, we examined the relationship of prena-
tal lead exposure (cord blood) and IQ score in
the subsample for which cord blood lead tests
were available.
Results
Of the 1,581 eligible children from the seven
cohorts, data on all 10 covariates were available
for 1,308 (83%) children; 1,333 (84%) chil-
dren had data on the four major covariates that
were selected for the final model (Table 1).
Blood lead levels were highest in Yugoslavia
and lowest in Rochester and Boston for all lead
exposure indices (Table 2). The median peak
or maximal blood lead concentration was
18 µg/dL; the mean age when children’s blood
lead levels peaked was 2.5 years. By 5–7 years
of age, the median blood level had declined to
9.7 µg/dL (concurrent blood lead concentra-
tion). The lifetime average blood lead concen-
tration was 12.4 µg/dL; 244 (18%) children
had a maximal blood lead concentration
< 10 µg/dL, and 103 (8%) had a maximal
blood lead concentration < 7.5 µg/dL.
The mean IQ of all children was approxi-
mately 93. Child IQ was highest in the Boston
cohort and lowest in the Yugoslavia cohort
(Table 2). In univariate regression analyses, chil-
dren’s IQ was signiﬁcantly related to site, mater-
nal IQ, the HOME score, maternal education,
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order, race (for U.S. cohorts only), and pre-
natal tobacco exposure. In contrast, child’s sex
and prenatal alcohol consumption were not
significantly associated with a deficit in IQ
score (Table 3).
We examined the relationship of the four
blood lead indices with IQ (Table 4). Although
all four blood lead measures were highly cor-
related (r range = 0.74–0.96), the concurrent
blood lead variable exhibited the strongest
relationship with IQ, as measured by R2.
Although the means differed for the different
blood lead indices, the results of the regres-
sion analyses were very similar. In all subse-
quent analyses and figures, the concurrent
blood lead measure was used as the primary
lead exposure index.
The shape of the exposure–response rela-
tionship was determined to be nonlinear insofar
as the quadratic and cubic terms for concurrent
blood lead were statistically significant (p <
0.001 and p = and 0.003, respectively). Because
the restrictive cubic spline indicated that a log-
linear model provided a good ﬁt to the data, we
used the log of concurrent blood lead in all sub-
sequent analyses of the pooled data (Figure 1).
The multivariable analysis resulted in a six-
term model: log of concurrent blood lead, site,
maternal IQ, HOME Inventory, birth weight,
and maternal education, which we consider
our preferred model (Table 4). Linear models
of concurrent blood lead and IQ are shown for
each of the seven cohorts, adjusted for the
same covariates (Figure 2). The additional six
terms we considered (child’s sex, birth order,
maternal age, marital status, prenatal smoking
status, and prenatal alcohol use) contributed
very little to the overall ﬁt of the model, and
their inclusion in the model resulted in virtu-
ally no change to the coefﬁcient for blood lead
(i.e., < 5%). None of the six terms was statisti-
cally signiﬁcant (data not shown).
The shape of the log-linear model and the
spline function indicated that the steepest
declines in IQ were at blood lead levels
< 10 µg/dL (Figures 3 and 4). The log-linear
model estimated a decrement of 6.9 IQ points
[95% conﬁdence interval (CI), 4.2–9.4] for an
increase in concurrent blood lead levels from
2.4 to 30 µg/dL, representing the 5th to the
95th percentile for blood lead values in the data
set (Table 4). But the lead-associated decrement
was greatest in the lower ranges of blood lead.
The estimated IQ decrements associated with
an increase in blood lead from 2.4 to 10 µg/dL,
10 to 20 µg/dL, and 20 to 30 µg/dL were 3.9
(95% CI, 2.4–5.3), 1.9 (95% CI, 1.2–2.6), and
1.1 (95% CI, 0.7–1.5), respectively (Table 4).
To investigate further whether the lead-
associated decrement was greater at lower blood
lead concentrations, we divided the data at two
cut-points a priori (i.e., maximal blood lead
above and below 10 µg/dL, and maximal blood
lead above and below 7.5 µg/dL) (Figure 4).
We then ﬁt separate linear models to the data
in each of these ranges and compared the blood
lead coefﬁcients for the concurrent blood lead
index. The coefficient for the 103 children
with maximal blood lead levels < 7.5 µg/dL
was signiﬁcantly greater than the coefﬁcient for
the 1,230 children with a maximal blood lead
Lanphear et al.
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Table 2. Characteristics of 1,333 children and their mothers in seven cohort studies of environmental lead exposure and IQ.
Boston Cincinnati Cleveland Mexico Port Pirie Rochester Yugoslavia
Characteristic (n = 116) (n = 221) (n = 160) (n = 99) (n = 324) (n = 182) (n = 231)
Percent femalea 60 (51.7) 108 (48.9) 73 (45.6) 50 (50.5) 174 (53.7) 89 (48.9) 115 (49.8)
Birth weightb (g) 3,412 ± 510 3,144 ± 457 3,199 ± 498 3,254 ± 432 3,393 ± 502 3,226 ± 506 3,328 ± 526
Gestation at deliveryb (weeks) 40.0 ± 1.8 39.6 ± 1.7 39.6 ± 1.2 40.2 ± 1.1 39.9 ± 1.7 39.1 ± 1.8 39.3 ± 2.9
Birth orderb 1.6 ± 1.0 2.6 ± 1.4 2.2 ± 1.1 1.8 ± 0.9 2.0 ± 1.1 2.4 ± 1.4 2.6 ± 1.7
IQ test WISC-R WISC-R WPPSI WISC-S WISC-R WPPSI WISC-III
IQ scoreb 116.0 ± 14.2 87.0 ± 11.4 86.7 ± 16.2 107.8 ± 11.0 106.0 ± 13.7 84.9 ± 14.4 74.2 ± 13.3
Age at IQ testing (years) 10 7 4.8 7 7 6 7
Blood lead concentrationsc
Concurrent blood lead 5.4 7.5 14.2 7.0 13.0 4.0 15.9
(0.8–12.7) (3.5–20.0) (7.0–28.5) (3.0–16.5) (6.0–24.0) (1.5–12.0) (4.7–47.8)
Peak blood lead 12.0 17.9 18.0 15.0 27.0 9.0 23.8
(5.4–27.0) (9.0–38.0) (9.0–34.0) (6.0–40.0) (15.0–46.0) (3.5–23.3) (7.6–61.5)
Early childhood 8.1 12.0 13.4 11.4 20.5 5.8 14.1
(3.3–18.0) (6.6–26.6) (7.9–24.8) (4.3–26.8) (11.0–33.3) (2.4–13.1) (4.3–44.0)
Lifetime mean 7.6 11.7 14.5 10.6 18.6 5.5 15.8
(3.6–15.2) (5.8–24.9) (8.1–25.3) (4.5–21.3) (10.8–30.2) (2.4–12.8) (5.6–49.3)
Peak blood lead < 10 µg/dLa 41 (35.3) 23 (10.4) 11 (6.9) 20 (20.2) 0 (0.0) 103 (56.6) 46 (19.9)
Peak blood lead < 7.5 µg/dLa 13 (11.2) 1 (0.4) 1 (0.6) 8 (8.1) 0 (0.0) 69 (37.9) 11 (4.8)
Maternal characteristics
Age at delivery (years)b 30.5 ± 4.2 22.7 ± 4.3 22.2 ± 3.8 27.1 ± 5.9 26.0 ± 4.2 24.8 ± 6.6 26.6 ± 5.1
Race (nonwhite)a 5 (4.3) 197 (89.1) 69 (43.1) NA NA 130 (71.4) NA
Maternal IQb 124.2 ± 16.2 75.2 ± 9.4 73.4 ± 13.2 93.4 ± 11.9 94.4 ± 11.0 81.1 ± 12.6 87.3 ± 14.8
Education at delivery (grade)b 15.2 ± 2.0 11.2 ± 1.4 10.6 ± 1.6 11.4 ± 3.5 10.6 ± 1.0 12.2 ± 2.0 8.8 ± 3.9
HOME scoreb 50.5 ± 3.5 32.7 ± 6.2 38.1 ± 6.7 36.8 ± 6.7 42.3 ± 4.6 31.9 ± 6.3 30.4 ± 6.8
Marrieda 107 (92.2) 30 (13.6) 82 (51.2) 88 (88.9) 298 (92.0) 60 (33.2) 231 (100)
Tobacco use during pregnancya 29 (25.0) 111 (50.2) 128 (80.0) 6 (6.1) 79 (24.6) 41 (22.6) 59 (25.5)
Alcohol use during pregnancya 61 (52.6) 31 (14.0) 75 (46.9) 6 (6.1) 82 (25.3) 9 (5.5) 14 (6.1)
NA, Not applicable. HOME score was standardized to preschool scale. Concurrent blood lead tests taken at 5 years of age were used as the concurrent blood lead test for the Boston
cohort, and the IQ test was done at 10 years. Test scores of children in the Yugoslavia cohort are low because of adjustments in adapting tests where no standardization existed; rather
than deriving appropriate analogues, some culturally driven items were removed, resulting in lower scores.
aNo. (%). bMean ± SD. cGeometric mean (5th–95th percentiles).
Table 1. Characteristics of the children and of their
mothers in the pooled analysis (n = 1,333).
Characteristic Value
Child characteristics
Femalea 669 (50.2)
Birth weightb (g) 3,286 ± 503
Gestation at deliveryb (weeks) 39.6 ± 1.9
Birth orderc 2.0 (1–5)
Blood lead concentrationc
Concurrent 9.7 (2.5–33.2)
Peak 18.0 (6.2–47.0)
Early childhood 12.7 (4.0–34.5)
Lifetime average 12.4 (4.1–34.8)
Peak blood lead 244 (18.3)
concentration < 10 µg/dLa
Peak blood lead 103 (7.7)
concentration < 7.5 µg/dLa
IQb 93.2 ± 19.2
Age at IQ testingb (years) 6.9 ± 1.2
Maternal characteristics
Age at deliveryb (years) 25.4 ± 5.4
Maternal IQb 88.2 ± 18.5
Education at deliveryb (grade) 11.1 ± 2.8
HOME scoreb 37.0 ± 8.4
Marrieda 896 (67.3)
Smoked during pregnancya 453 (34.1)
Alcohol use during pregnancya 278 (21.2)
HOME score was standardized to preschool test. Early
childhood blood lead concentration was defined as the
mean of 6- to 24-month blood lead tests. Lifetime average
blood lead concentration was deﬁned as the mean of blood
lead tests taken from 6 months through the concurrent
blood lead test.
aNo. (%). bMean ± SD. cMedian (5th–95th percentiles).≥ 7.5 µg/dL [linear β = –2.94 (95% CI, –5.16
to –0.71) vs. –0.16 (95% CI, –2.4 to –0.08);
p = 0.015]. The coefﬁcient for the 244 children
who had a maximal blood lead < 10 µg/dL was
not signiﬁcantly greater than the coefﬁcient for
the 1,089 children who had a maximal blood
lead ≥ 10 µg/dL [linear β = –0.80 (95% CI,
–1.74 to –0.14) vs. β = –0.13 (95% CI, –2.3 to
–0.03); p = 0.103].
To assess the model stability, we employed
a random-effects model with sites assumed to
be randomly selected from a larger set of popu-
lations. Results were similar to the preferred
fixed-effects model, with the random-effects
model producing a blood lead coefﬁcient that
was 3.7% lower (–2.6 vs. –2.7). As an addi-
tional measure of model stability, we ﬁt seven
identical log-linear models with each model
omitting data from one of the sites. The range
of coefficients leaving one site out at a time
was –2.36 (Rochester) to –2.94 (Yugoslavia),
or a percent change ranging from –2.6 to
+8.9%. These analyses provide evidence of
the stability of our ﬁnal preferred ﬁxed-effects
model and indicate that the results of the
pooled analysis did not depend on the data
from any single study.
We also examined the relation of blood
lead concentration to verbal and performance
IQ scores, adjusting for the same covariates
used in the full-scale IQ model. The coefﬁcient
for the log of blood lead related to performance
IQ was similar to the coefficient for log of
blood lead in the full-scale IQ model (β =
–2.73 vs. –2.70), whereas the coefficient for
log of blood lead related to verbal IQ was
somewhat lower than the coefﬁcient for the log
of blood lead in the full-scale IQ model (β =
–2.07 vs. –2.70). The difference between the
coefﬁcient for verbal and performance IQ was
not statistically signiﬁcant (p = 0.196).
We did not identify any signiﬁcant inter-
actions between the covariates and the log of
concurrent blood lead. In the U.S. sites, race
was not signiﬁcantly associated with IQ after
inclusion of the four covariates in the preferred
model, nor did it alter the estimated relation-
ship of blood lead concentration and IQ. In
unadjusted analyses involving the 696 children
who had cord blood lead levels, the log of cord
blood lead concentration was signiﬁcantly asso-
ciated with child’s IQ (β = –1.69, SE = 0.60;
p = 0.005). After adjusting for the log of con-
current blood concentration, the log of cord
blood lead was no longer associated with chil-
dren’s IQ scores (p = 0.21). In contrast, the log
of concurrent blood lead was signiﬁcantly asso-
ciated with children’s IQ scores even with log
cord blood lead concentration in the model
(β = –1.73, SE = 0.74; p = 0.019). Finally, we
identiﬁed and removed 65 potentially inﬂuen-
tial observations from the data and refit the
model. The change in the coefﬁcient for log of
blood lead was 1.4%, from –2.70 to –2.74.
Discussion
Before 1970, undue lead exposure was deﬁned
by a blood lead level of 60 µg/dL or higher—a
level often associated with overt signs or symp-
toms of lead toxicity, such as abdominal colic,
anemia, encephalopathy, and death. Since
then, the blood lead concentration for deﬁning
undue lead exposure has been reduced: from
60 to 40 µg/dL in 1971, to 30 µg/dL in 1978,
and to 25 µg/dL in 1985 (CDC 1991). In
1991, the CDC, and subsequently the WHO
(1995), further reduced the blood lead value
defining undue lead exposure to 10 µg/dL
(CDC 1991). These ongoing reductions in the
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Table 3. Concurrent blood lead concentration and mean IQ scores by characteristics of children and their
mothers (n = 1,333).
Median concurrent
blood lead (µg/dL)
Covariate No. (5th–95th percentiles) IQ ± SD
Child
Female 669 9.0 (2.4–31.4) 93.8 ± 18.3
Male 664 9.9 (2.6–35.7) 92.5 ± 20.0
Birth weight (g)
< 3,000 359 10.0 (2.2–28.7) 88.6 ± 18.0
3,000 to < 3,500 519 9.9 (2.4–34.2) 93.6 ± 19.3
≥ 3,500 455 9.1 (2.8–34.7) 96.3 ± 19.3
Gestation at delivery (weeks)
< 38 144 8.9 (3.1–37.9) 83.5 ± 18.6
38 to < 42 1,071 9.8 (2.5–33.2) 94.1 ± 18.6
≥ 42 115 10.0 (3.2–24.8) 96.3 ± 22.1
Birth order
1 479 9.0 (2.1–32.6) 96.7 ± 18.9
2 407 10.0 (2.6–31.4) 93.6 ± 19.2
≥ 3 446 10.0 (3.0–36.9) 89.0 ± 18.7
Maternal
Race (only U.S. cohorts)
White 278 7.9 (1.3–22.0) 100.6 ± 20.1
Nonwhite 401 7.1 (2.8–21.5) 84.9 ± 12.8
Age at delivery (years)
< 25 650 10.5 (3.0–32.0) 89.6 ± 17.2
≥ 25 683 9.0 (2.1–34.7) 96.5 ± 20.3
Maternal IQ
< 85 618 10.0 (2.9–32.0) 83.3 ± 15.0
≥ 85 715 9.0 (2.1–34.3) 101.6 ± 18.3
Education at delivery (grade)
< 12 710 12.0 (4.1–35.5) 90.4 ± 18.8
12 397 8.7 (2.4–34.3) 91.1 ± 17.7
≥ 12 226 5.5 (1.1–15.2) 105.5 ± 18.0
HOME score
< 30 276 9.4 (3.0–43.0) 77.9 ± 14.9
30 to < 40 561 10.0 (2.8–32.2) 88.3 ± 15.4
≥ 40 496 9.5 (2.0–22.0) 107.0 ± 15.8
Married
Yes 896 10.0 (2.7–37.5) 96.2 ± 20.5
No 436 8.1 (2.4–22.0) 87.0 ± 14.3
Prenatal smoking
Yes 453 11.5 (3.2–33.2) 89.5 ± 17.2
No 876 8.7 (2.2–33.6) 94.9 ± 19.9
Prenatal alcohol ingestion
Yes 278 10.1 (2.2–25.0) 99.3 ± 19.4
No 1,035 9.5 (2.7–34.3) 91.7 ± 18.8
Table 4. Mean unadjusted and adjusteda changes in full-scale IQ score associated with an increase in
blood lead concentration (log scale), from the 5th to 95th percentile of the concurrent blood lead level at
the time of IQ testing.
Blood lead IQ deﬁcits
Unadjusted Adjusted concentration [5th to 95th
estimates estimates (5th to 95th percentile
Blood lead variable [β (95% CI)] [β (95% CI)] percentile, µg/dL) (95% CI)]
Early childhood –3.57 (–4.86 to –2.28) –2.04 (–3.27 to –0.81) 4.1–34.8 4.4 (1.7–7.0)
Peak –4.85 (–5.16 to –3.54) –2.85 (–4.10 to –1.60) 4.0–34.5 6.1 (3.4–8.8)
Lifetime average –5.36 (–6.69 to –4.03) –3.04 (–4.33 to –1.75) 6.1–47.0 6.2 (3.6–8.8)
Concurrent –4.66 (–5.72 to –3.60) –2.70 (–3.74 to –1.66) 2.4–33.1 7.1 (4.4–9.8)
aAdjusted for site, HOME score, birth weight, maternal IQ, and maternal education. The addition of child’s sex, tobacco
exposure during pregnancy, alcohol use during pregnancy, maternal age at delivery, marital status, and birth order did
not alter the estimate, and these were not included in the model. The estimates for the covariates in the concurrent blood
lead model were HOME score (β = 4.23, SE = 0.54), birth weight/100 g (β = 1.53, SE = 0.35), maternal IQ (β = 4.77, SE = 0.57),
and maternal education (β = 1.12, SE = 0.46).acceptable levels of children’s blood lead were
motivated by evidence showing that blood lead
concentrations as low as 10 µg/dL were associ-
ated with adverse effects, such as lower intelli-
gence (CDC 1991; WHO 1995).
In this pooled analysis, we found evidence
of lead-related intellectual deficits among
children who had maximal blood lead levels
< 7.5 µg/dL. Indeed, we found no evidence of
a threshold. Other studies reported a similar
ﬁnding, but questions about the relationship at
lower levels remained because they involved
smaller numbers of children with blood lead
< 10 µg/dL or they did not adjust for impor-
tant covariates (Canfield et al. 2003; Fulton
et al. 1987; Lanphear et al. 2000; Schwartz
1994; Schwartz and Otto 1991; Walkowiak
et al. 1998). In the pooled analysis, we esti-
mated the blood lead–IQ relationship with
data from the 5th to 95th percentile of the con-
current blood lead level at the time of IQ test-
ing, which tends to underestimate the adverse
effects of blood lead levels. For the entire
pooled data set, the observed decline of 6.2 IQ
points (95% CI, 3.8–8.6) for an increase in
blood lead levels from < 1 to 10 µg/dL was
comparable with the 7.4 IQ decrement for an
increase in lifetime mean blood lead levels from
< 1 to 10 µg/dL observed in the Rochester
Longitudinal Study (Canﬁeld et al. 2003).
Consistent with other studies (Bellinger
and Needleman 2003; Canfield et al. 2003;
Fulton et al. 1987; Lanphear et al. 2000;
Schwartz 1994; Schwartz and Otto 1991;
Walkowiak et al. 1998), the lead-associated
IQ deficits observed in this pooled analysis
were significantly greater at lower blood
lead concentrations. In a meta-analysis, the
observed decrement was greater in study
cohorts in which children with blood lead
levels < 15 µg/dL were more heavily repre-
sented (Schwartz 1994). In the Rochester
Longitudinal Study, there was an estimated
reduction of 7.4 IQ points for an increase in
lifetime mean blood lead from 1 to 10 µg/dL
(Canﬁeld et al. 2003). In contrast, IQ scores
declined 2.5 points for an increase in blood lead
concentration from 10 to 30 µg/dL (Canﬁeld
et al. 2003). The larger sample size of this
pooled analysis permitted us to show that the
lead-associated intellectual decrement was sig-
niﬁcantly greater for children with a maximal
blood lead of < 7.5 µg/dL than for those who
had a maximal blood lead of ≥ 7.5 µg/dL.
Although the difference in coefﬁcients associated
with the IQ decrement for children who had a
maximal blood lead concentration < 10 µg/dL
versus ≥ 10 µg/dL was not statistically signiﬁ-
cant, the results were consistent with the analysis
using 7.5 µg/dL as a cut-point.
We found that concurrent blood lead lev-
els or average lifetime estimates of lead expo-
sure were generally stronger predictors of
lead-associated intellectual deficits than was
maximal measured (peak) or early childhood
blood lead concentration. Although this ﬁnd-
ing conﬂicts with the widely held belief that
2-year (or peak) blood lead levels are the most
salient measure of lead toxicity, there is
increasing evidence that lifetime mean blood
lead and concurrent blood lead levels are
stronger predictors of IQ in older children
(Baghurst et al. 1992; Canfield et al. 2003;
Dietrich et al. 1993; Factor-Litvak et al.
1999). The stronger effects of concurrent and
lifetime measures of lead exposure may be
due to chronicity of exposure (Bellinger and
Dietrich 1994). Alternatively, the weaker
association with blood lead measured during
early childhood may be due to exposure mis-
classification from the greater within-child
variability of blood lead in younger children.
Nevertheless, because blood lead concentra-
tions taken in early childhood track closely
with subsequent blood lead levels (Baghurst
et al. 1992; Canfield et al. 2003; Dietrich
et al. 1993), we cannot entirely resolve the
question of whether children are more vulner-
able to lead exposure during the ﬁrst 2 years
of life. Still, young children do ingest more
lead during the first 2 years of life and may
absorb it more efﬁciently than do older chil-
dren and adults (Clark et al. 1985; Lanphear
et al. 2002; Ziegler et al. 1978). Thus, efforts
to prevent lead exposure must occur before
pregnancy or a child’s birth.
The speciﬁc mechanisms for lead-induced
intellectual deﬁcits have not been fully eluci-
dated. There are several plausible mechanisms
for the greater lead-associated intellectual
deﬁcits observed at blood lead levels < 10 µg/dL
(Lidsky and Schneider 2003; Markovac and
Goldstein 1988; Schneider et al. 2003), but it is
not yet possible to link any particular mecha-
nism with the deﬁcits observed in this pooled
analysis. Nevertheless, efforts can be taken to
reduce environmental lead exposure without
full elucidation of the underlying mechanism
(Wynder 1994).
The observational design of this study
limits our ability to draw causal inferences.
Instead, we must rely on the consistency of
findings from numerous epidemiologic and
experimental studies in rodents and nonhuman
primates, including evidence that environ-
mental lead exposure is associated with intellec-
tual deficits at blood lead levels < 10 µg/dL.
There are potential limitations of the tools we
used to measure important covariates. The
HOME Inventory was not conducted at the
same age for children in all of the sites, and the
HOME Inventory and IQ tests have not been
validated in all cultural or ethnic communities.
Nonetheless, because these covariates were
standardized and adjusted for study site, these
problems do not pose any limitations to the
interpretation of the pooled analysis results.
Lanphear et al.
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Figure 1. Restricted cubic splines and log-linear
model for concurrent blood lead concentration.
The dotted lines are the 95% CIs for the restricted
cubic splines.
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Figure 2. Linear models for each cohort study in the
pooled analysis, adjusted for maternal IQ, HOME
score, maternal education, and birth weight. The
figure represents the 5th to 95th percentile of the
concurrent blood lead level at the time of IQ testing.
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Figure 3. Log-linear model (95% CIs shaded) for
concurrent blood lead concentration, adjusted for
HOME score, maternal education, maternal IQ, and
birth weight. The mean IQ (95% CI) for the intervals
< 5 µg/dL, 5–10 µg/dL, 10–15 µg/dL, 15–20 µg/dL,
and > 20 µg/dL are shown.
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Figure 4. Log-linear model for concurrent blood
lead concentration along with linear models for
concurrent blood lead levels among children with
peak blood lead levels above and below 10 µg/dL.
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There are other predictors of neurodevelop-
mental outcomes that we did not examine in
this pooled analysis, such as maternal depres-
sion. The omission of unmeasured variables
may produce residual confounding (Pocock
et al. 1994). Still, in studies that did examine
other relevant covariates, such as breast-feeding
and iron status, the estimated effect of lead was
not altered appreciably (Canﬁeld et al. 2003;
Needleman et al. 1990; Tong and Lu 2000).
Finally, each of the cohorts has unique limita-
tions that raise questions about the validity and
generalizability of their ﬁndings. Nevertheless,
the results of these analyses indicate that the
results are robust and not dependent on the
data from any one site.
The impact of low-level environmental
lead exposure on the health of the public is
substantial. This pooled analysis focused on
intellectual deficits, but environmental lead
exposure has been linked with an increased
risk for numerous conditions and diseases that
are prevalent in industrialized society, such as
reading problems, school failure, delinquent
behavior, hearing loss, tooth decay, sponta-
neous abortions, renal disease, and cardio-
vascular disease (Borja-Aburto et al. 1999;
Dietrich et al. 2001; Factor-Litvak et al. 1999;
Lin et al. 2003; Moss et al. 1999; Nash et al.
2003; Needleman et al. 2002; Schwartz and
Otto 1991). Although only a few studies have
examined the association of these conditions
or diseases among individuals with blood
lead levels < 10 µg/dL (Borja-Aburto et al.
1999; Lanphear et al. 2000; Moss et al. 1999;
Schwartz and Otto 1991), the evidence is
growing.
In conclusion, the results of this pooled
analysis underscore the increasing importance
of primary prevention as the consequences of
lower blood lead concentrations are recognized.
Although blood lead concentrations < 10 µg/dL
in children are often considered “normal,” con-
temporary blood lead levels in children are
considerably higher than those found in pre-
industrial humans (Patterson et al. 1991).
Moreover, existing data indicate that there is no
evidence of a threshold for the adverse conse-
quences of lead exposure. Collectively, these
data provide sufficient evidence to eliminate
childhood lead exposure by banning all
nonessential uses of lead and further reducing
the allowable levels of lead in air emissions,
house dust, soil, water, and consumer products
(Lanphear 1998; Rosen and Mushak 2001).
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